AmeriTrust Announces Closing First Tranche of Brokered Offering for $36,187,200

Executive Summary
- AmeriTrust Financial Technologies Inc. closed the first tranche of its brokered offering, raising $36,187,200 in aggregate gross proceeds.
- The tranche consisted of 20,850 Debenture Units at $1,000 each (including senior unsecured convertible debentures and ~11,765 common share purchase warrants per unit) and 306,744,000 Life Units at $0.05 each (each comprising one common share and one warrant).
- Proceeds are earmarked to restart lease originations in Q1 2026 and for general working capital; a second tranche is expected to close around January 6 2026.
Key Details
- Debenture Units: 20,850 units @ $1,000 = $20,850,000 gross proceeds.
-
Each unit contains:
- One senior unsecured convertible debenture (principal $1,000, 8% annual interest, quarterly payments starting 31 Mar 2026, maturing 5 years from closing).
- Approximately 11,765 common‑share purchase warrants at an exercise price of $0.12 per share.
- Warrants exercisable 60 days after the Closing Date through 60 months thereafter, with early acceleration if TSXV VWAP ≥ $0.30 for 30 consecutive trading days after 18 months.
-
Life Units: 306,744,000 units @ $0.05 = $15,337,200 gross proceeds.
-
Each unit consists of one common share and one warrant (exercise price $0.12, same terms as above).
-
Agent Compensation:
- Cash commission to Clarus Securities Inc. and Cormark Securities Inc.: $1,264,740.
-
Issuance of 14,878,000 common‑share purchase warrants to the agents (exercise price C$0.05, exercisable until 23 Dec 2027).
-
Related Party Transaction: Insiders participated in the first tranche; the transaction is exempt from formal valuation and minority‑shareholder approval under MI 61‑101. A material change report will be filed post‑closing with additional details.
-
Statutory Hold Periods:
- Debenture Units & Broker Warrants subject to hold until 24 Apr 2026.
-
Life Units have no statutory hold period.
-
Option for Additional Units: Agents may issue up to $6,000,000 of additional proceeds (max $1,980,000 for Life Units) before the second tranche closes.
-
Use of Proceeds: Funding will support the restart of lease originations (“flow” and “haircut” capital) in Q1 2026 and provide working‑capital liquidity.
-
Second Tranche: Anticipated closing on or about 6 Jan 2026; subject to final TSXV acceptance.
Notable Quotes
(No direct quotes were provided in the release.)